Faecal microbiota transplantation for severe clostridium difficile infection in the intensive care unit
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
We describe a case of faecal microbiota transplantation (FMT) used for severe binary toxin-positive Clostridium difficile infection in an intensive care setting. The patient was admitted to the ICU of a tertiary hospital and failed traditional maximal pharmacological management. Adjunctive therapy with FMT given through gastroscopy resulted in resolution of the C. difficile-related symptoms. Although there is a growing experience with FMT for recurrent C. difficile infection, published evidence in severe disease is very limited. In a landscape of increasingly severe C. difficile infection, adjunctive FMT may be considered a useful early treatment option.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“however a few case reports suggest that it may be safe and effective even in critically ill patients18–21.”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [20]
Citations
Cites
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Louie, T. J., Miller, M. A., Mullane, K. M., Weiss, K., Lentnek, A., Golan, Y., Gorbach, S., Sears, P., & Shue, Y.-K. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0910812 · Cited by 1,585
Zar, F. A., Bakkanagari, S. R., Moorthi, K. M. L. S. T., & Davis, M. B. (2007) · Clinical Infectious Diseases · doi:10.1086/519265 · Cited by 1,252
(1958) · PubMed · Cited by 978
Treatment with Monoclonal Antibodies against Clostridium difficile Toxins
Lowy, I., Molrine, D. C., Leav, B. A., Blair, B. M., Baxter, R., Gerding, D. N., Nichol, G., Thomas, W. D., Leney, M., Sloan, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907635 · Cited by 746
Khoruts, A., Dicksved, J., Jansson, J. K., & Sadowsky, M. J. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181c87e02 · Cited by 649
Surawicz, C. M., McFarland, L. V., Greenberg, R. N., Rubin, M., Fekety, R., Mulligan, M. E., Garcia, R. J., Brandmarker, S., Bowen, K., Borjal, D., et al. (2000) · Clinical Infectious Diseases · doi:10.1086/318130 · Cited by 529
Aas, J., Gessert, C. E., & Bakken, J. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367657 · Cited by 518
The outcome of surgery in fulminant Clostridium difficile colitis
Koss, K., Clark, M. A., Sanders, D. S. A., Morton, D., Keighley, M. R. B., & Goh, J. (2006) · Colorectal Disease · doi:10.1111/j.1463-1318.2005.00876.x · Cited by 184
Yoon, S. S., & Brandt, L. J. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181dac035 · Cited by 178
Herpers, B. L., Vlaminckx, B., Burkhardt, O., Blom, H., Biemond‐Moeniralam, H. S., Hornef, M., Welte, T., & Kuijper, E. J. (2009) · Clinical Infectious Diseases · doi:10.1086/599224 · Cited by 164
Successful Treatment of Fulminant Clostridium difficile Infection with Fecal Bacteriotherapy
You, D. M., Franzos, M. A., & Holman, R. P. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-8-200804150-00024 · Cited by 99
Struggling with recurrent Clostridium difficile infections: is donor faeces the solution?
van Nood, E., Speelman, P., Kuijper, E. J., & Keller, J. J. (2009) · Eurosurveillance · doi:10.2807/ese.14.34.19316-en · Cited by 99
Cheng, A. C., Ferguson, J. K., Richards, M. J., Robson, J. M., Gilbert, G. L., McGregor, A., Roberts, S., Korman, T. M., & Riley, T. V. (2011) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2011.tb03006.x · Cited by 87
Brandt, L. J., Borody, T. J., & Campbell, J. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182257d4f · Cited by 73
Gallegos-Orozco, J. F., Paskvan-Gawryletz, C., Gurudu, & Orenstein, R. (2012) · PubMed · Cited by 27
Research works printed but not linked: 3
- Brandt, 2011, First-Line treatment for severe Clostridium difficile infection J Clin Gastroenterol, 45, 655
- Eiseman, 1958, Surgery, 44, 854
- Gallegos-Orozco, 2012, Rev Gastroenterol Mex, 77, 40
Cited by
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
DeFilipp, Z., Bloom, P. P., Torres Soto, M., Mansour, M. K., Sater, M. R. A., Huntley, M. H., Turbett, S., Chung, R. T., Chen, Y.-B., & Hohmann, E. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1910437 · Cited by 1,281
Therapeutic Potential of Fecal Microbiota Transplantation
Smits, L. P., Bouter, K. E. C., de Vos, W. M., Borody, T. J., & Nieuwdorp, M. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.058 · Cited by 717
Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook
Kelly, C. R., Kahn, S., Kashyap, P., Laine, L., Rubin, D., Atreja, A., Moore, T., & Wu, G. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.008 · Cited by 572
Cammarota, G., Ianiro, G., & Gasbarrini, A. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000046 · Cited by 428
“Rubin et al31 USA 74 63 (6-94) Recurrent (2 or more) Stomach/ nasogastric tube 64) Percutaneous gastrostomy tube (4) Upper endoscopy (7) 30/50-70 59/57 12wk O: M-V”
BackgroundInfluentialSystematic Review: Adverse Events of Fecal Microbiota Transplantation
Wang, S., Xu, M., Wang, W., Cao, X., Piao, M., Khan, S., Yan, F., Cao, H., & Wang, B. (2016) · PLOS ONE · doi:10.1371/journal.pone.0161174 · Cited by 409
“) Definitely related to FMT Probably related to FMT Possibly related to FMT Unrelated to FMT Mellow, 2011 [77] CDI relapse Death from pneumonia; Death from superior mesenteric vein thrombosis; Death from ovarian cancer Aas, 2003 [62] Death from peritonitis Death from pneumonia Mandalia, 2014 [78] Diverticulitis; Fever…”
Metadata
- Authors
- Trubiano, J. A., Gardiner, B., Kwong, J. C., Ward, P., Testro, A. G., & Charles, P. G. P.
- Affiliations
- Austin Hospital (AU)
- Austin Health (AU)
- The University of Melbourne (AU)
- Corresponding author
- Trubiano, Jason A.
- Venue
- European Journal of Gastroenterology & Hepatology
- Published
- 2013-02
- Volume
- 25
- Issue
- 2
- Pages
- 255-257
- ISSN
- 0954-691X (ISSN-L)
- OpenAlex
- W2324833893
- Cited by
- 64
- References
- 15
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 1 · 2022: 2 · 2021: 6 · 2020: 3 · 2019: 5 · 2018: 6 · 2017: 4 · 2016: 10 · 2015: 8 · 2014: 10 · 2013: 4
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- fecal microbiota transplantation, Clostridium difficile infection, serious infections, intensive care unit, adjunctive therapy, recurrent Clostridium difficile infection
- MeSH terms
- Aged, Combined Modality Therapy, Critical Care, Enterocolitis, Pseudomembranous, Feces, Female, Gastroscopy, Humans, Clostridioides difficile, Fatal Outcome, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.